MSCAST- ام اس کست

Episode 34: Aging in MS

Tue, 07 Mar 2023 20:42:00 +0000

In this episode we talked about geriatric MS with dr. Iman Adibi

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 33: Journal watch - 2022 highlights

Mon, 30 Jan 2023 14:20:00 +0000

Here in the 33rd episode, we continue the 2022 journal highlights with Dr. Adibi

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 32: Journal watch - 2022 highlights

Tue, 17 Jan 2023 12:30:00 +0000

Here in the 32th episode we go through 2022 journal highlights with Dr. Adibi

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 31: Pregnancy and lactation

Tue, 03 Jan 2023 20:40:00 +0000

in the 31st episode of MS Cast, we talked about Pregnancy and lactation in people diagnosed with MS together with Dr. Adibi

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 30: Post ECTRIMS Congress

Wed, 21 Dec 2022 11:54:00 +0000

Episode 30

a post-congress episode

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 29: pediatrics

Tue, 13 Dec 2022 13:00:00 +0000

Episode 29

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 28: Diagnosis Pitfall

Tue, 22 Nov 2022 06:20:00 +0000

Episode 28

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 27: Break through and Scalation

Mon, 07 Nov 2022 17:00:00 +0000

Episode 27

in this episode we talk about breaking through and scalation of MS with Dr. Iman Adibi

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 26: response monitoring tools

Mon, 24 Oct 2022 15:10:00 +0000

Episode 26

this episode talks about response monitoring tools of MS treatment with Dr. Iman Adibi

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 25: New Treatments, New Drugs

Mon, 10 Oct 2022 16:50:00 +0000

Episode 25

this episode talks about new treatments and new drugs of MS treatment with Dr. Iman Adibi

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 24: Efficacy of MS treatments

Mon, 26 Sep 2022 16:50:00 +0000

Episode 24

this episode talks about the Efficacy of MS treatments with Dr. Iman Adibi

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 23: First line of MS treatment

Mon, 12 Sep 2022 15:45:00 +0000

Episode 23

this episode talks about First line treatment of MS with Dr. Iman Adibi

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 22: Journal Watch 2

Mon, 05 Sep 2022 16:18:00 +0000

episode 22

this episode is a Journal watch to review some article with Dr. Iman Adibi

DOI of the first study:

DOI of the second study:

DOI of the first study:10.3340/jkns.2021.0195

http://doi.org/1 0.3340/jkns.2021.0195

DOI of the second study:10.1136/jnnp-2022-329227

http://dx.doi.org/10.1136/jnnp-2022-329227

DOI of the third study: 10.2217/nmt-2022-0009

https://doi.org/10.2217/nmt-2022-0009

10.1177/13524585221102587:DOI of the fourth study

https://doi.org/10.1177%2F13524585221102587

DOI of the fifth study: 10.1093/braincomms/fcac181

https://doi.org/10.1093/braincomms/fcac181

DOI of the sixth study: 10.3390/biomedicines10071629

https://doi.org/10.3390/biomedicines10071629

DOI of the seventh study: 10.3390/brainsci12070954

https://doi.org/10.3390/brainsci12070954

DOI of the eighth study: 10.1016/j.jcrc.2022.153985

https://doi.org/10.1016/j.jcrc.2022.153985

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 21: EAN2022-post congress episode

Mon, 15 Aug 2022 16:30:00 +0000

In this episode, we are talking about recent topics of MS in EAN 2022

___

thank's Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

Episode 20: EBV and MS relationship

Mon, 01 Aug 2022 16:00:00 +0000

episode 20 talks about the Epstein-Barr virus (EBV) and MS relationship

DOI of the study: 10.1212/WNL.0b013e318215286d

https://doi.org/10.1212/WNL.0b013e318215286d

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 19: Journal watch

Mon, 25 Jul 2022 13:30:00 +0000

episode 19

this episode talks about Journal watch

DOI of the first study: 10.1007/s00415-022-11205-9

https://doi.org/10.1007/s00415-022-11205-9

DOI of the second study:10.1007/s00415-022-11215-7

https://doi.org/10.1007/s00415-022-11215-7

DOI of the third study: 10.1016/j.msard.2021.103437

https://doi.org/10.1016/j.msard.2021.103437

DOI of the fourth study:10.3389/fimmu.2022.834644

https://doi.org/10.3389/fimmu.2022.834644

DOI of the fifth study: 10.1016/j.msard.2022.103638

https://doi.org/10.1016/j.msard.2022.103638

DOI of the sixth study: 10.1016/j.msard.2022.103760

https://doi.org/10.1016/j.msard.2022.103760

thank Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 18: Treatment optimization

Mon, 18 Jul 2022 14:00:00 +0000

episode 18 talks about treatment optimization

DOI of first study:

https://doi.org/10.1007/s00415-020-10074-4

DOI of second study:

http://dx.doi.org/10.1136/jnnp.2008.145805

thank's Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 17:Patient profile & prognostication'

Mon, 11 Jul 2022 16:20:00 +0000

episode 17

This episode talks

about Patient profile & prognostication in Multiple Sclerosis

DOI of study:10.1016/j.msard.2021.102854

https://www.sciencedirect.com/science/article/pii/S2211034821001206

Thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 16:Pregnancy Management in Multiple Sclerosis and Other Demyelinating Diseases

MSCAST — Fri, 18 Mar 2022 07:21:38 +0000

episode 16

This episode talks

about Pregnancy Management in Multiple Sclerosis and Other Demyelinating Diseases

DOI of study:10.1212/CON.0000000000001108

https://journals.lww.com/continuum/Abstract/2022/02000/Pregnancy_Management_in_Multiple_Sclerosis_and.4.aspx

Thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 15:Treatment Optimization in MS

MSCAST — Mon, 07 Mar 2022 16:04:13 +0000

episode 15

The second episode talks

about Canadian MS Working Group

Updated Recommendations

and switching medication position

DOI of study:10.1017/S0317167100014244

https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/treatment-optimization-in-ms-canadian-ms-working-group-updated-recommendations/F7CA82BA3ADDD05DB9EF45D60802DE01

Thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 14:Treatment Optimization in MS

MSCAST — Mon, 28 Feb 2022 16:30:00 +0000

episode 14

The first episode talks

about Canadian MS Working Group

Updated Recommendations

and switching medication position

DOI of study:10.1017/S0317167100014244

Thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 13:LIVER INJURY & Side effect of MS Agents

MSCAST — Mon, 21 Feb 2022 20:25:46 +0000

episode 13

This episode talks

about common side effects of ms medication

and necessary tests for screening

Thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 12:Myelitis AND Autoimmune Myelopathy in spinal cord

MSCAST — Mon, 14 Feb 2022 20:19:25 +0000

episode 12

The last episode talks about Myelitis AND Autoimmune Myelopathy in spinal cord category in continuum Feb 2021

DOI of study:10.1007/978_3_030_61883-4_27

https://books.google.com/books?hl=en&lr=&id=qTsiEAAAQBAJ&oi=fnd&pg=PA433&dq=Myelitis%2BAutoimmune%2BMyelopathy%2Bspinal+cord%2Bcategory+(continuum)+++2021+&ots=PjTEg13DQM&sig=k0EDBMPko9wyv1favu1Lyofd9Qs#v=onepage&q&f=false

Journal watch:

first Article: Self-perceived versus physician documented adverse events in patients with multiple sclerosis REGIMS - a pharmacovigilance registry for patients with multiple sclerosis in Germany

DOI of study:10.1016/j.msard.2022.103684

https://www.sciencedirect.com/science/article/pii/S2211034822001997?casa_token=0DubVZHjMksAAAAA:_67S9LFKMd-VMqabUiNu9yykFeMZoIyOTi7Xt12J287ELGxN-opERpEnRbjilauBY-NUK9KfIw

second Article: Telemedicine during the Coronavirus Disease (COVID-19) Pandemic: A Multiple Sclerosis (MS) Outpatients Service Perspective

DOI of study:10.3390/neurolint13010003

https://www.mdpi.com/2035-8377/13/1/3

Third Article: Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients

DOI of study:10.1186/s12974-021-02339-0

https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-021-02339-0

Thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 11:Myelitis AND Autoimmune Myelopathy in spinal cord

MSCAST — Mon, 07 Feb 2022 16:40:26 +0000

episode 11

The second episode talks about Myelitis AND Autoimmune Myelopathy in spinal cord category in continuum Feb 2021

DOI of study:10.1007/978_3_030_61883-4_27

with Journal watch

https://www.nanoalvand.com/

episode 10:Myelitis AND Autoimmune Myelopathy in spinal cord

MSCAST — Mon, 31 Jan 2022 16:13:28 +0000

episode 10

The first episode talks about Myelitis AND Autoimmune Myelopathy in spinal cord category in continuum Feb 2021

DOI of study:10.1007/978_3_030_61883-4_27

Journal watch:

first Article: Recovery From COVID-19 in Multiple Sclerosis A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register

DOI of study:10.1212/NXI.0000000000001118

https://nn.neurology.org/content/9/1/e1118.abstract

second Article: Impact of Ramadan fasting on disease activity in patients with multiple sclerosis: a multicenter study

DOI of study:10.1080/1028415X.2021.2006955

https://www.tandfonline.com/doi/abs/10.1080/1028415X.2021.2006955

Third Article: Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes

DOI of study:10.1371/journal.ppat.1009618

https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.10096181

Thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode9:last episode of MRI in patients with multiple sclerosis

MSCAST — Tue, 18 Jan 2022 12:48:40 +0000

episode 9

The last episode talks about global protocol of MRI in MS patients:

1)Optic nerve

2)Review of the whole study

3)Estimation of future of Subject

DOI of study:10.1016/S1474-4422(21)00095-8

https://www.sciencedirect.com/science/article/abs/pii/S1474442221000958t

Journal watch:

first Article: A proinflammatory diet is associated with an increased likelihood of first clinical diagnosis of central nervous system demyelination in women

DOI of study:10.1016/j.msard.2021.103428

https://www.sciencedirect.com/science/article/abs/pii/S2211034821006945?casa_token=5T_-6p6QM_kAAAAA:2mHpWvxMNEqyys25_KtJiPDk5tRn3n1t6R_UMw2Fq_o5gjzErM7IgxCnvtDMKo0PS8pIrqdTdA

second Article: The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis

DOI of study:10.1371/journal.pone.0256845

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256845

Third Article: Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden

DOI of study:10.1001/jamanetworkopen.2021.36697

https://jamanetwork.com/journals/jamanetworkopen/article-abstract/2786701

Thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 8:Covid-19 Demyelination

MSCAST — Thu, 18 Nov 2021 16:57:32 +0000

episode 8

talking about Covid-19 Demyelination in journal of neuroimmunology

DOI of study:10.1016/j.jneuroim.2021.577765

https://www.sciencedirect.com/science/article/pii/S0165572821002927

thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode7:MRI in patients with multiple sclerosis...

MSCAST — Mon, 15 Nov 2021 16:29:03 +0000

episode 7

continue talking about global protocol of MRI in MS patients:

1)اگر در ام ار ای کرایتریای تشخیصی را پر نکندبا چه بازه ای باید ام ار ای را تکرار کرد؟

2)به غیر از ام ار ای بیس لاین در چه زمان هایی ام ار ای با کنتراست لازم است؟

3)با توجه به اینکه گادلنیوم کم عارضه است،این همه حساسیت از کجا می آید؟

4)کاربرد ام ار ای در مانیتورینگ بیماری چیه؟

5) با توجه به محدودیت روش های اتوماتیک تحلیل تصویر اطلاعات مانیتورینگ یا کشف پلاک جدید یا کلا تغییرات در ام ار ای کمک کننده است؟

6)پلاک های کورتکس در مانیتورینگ چه نقشی دارند؟

7)نکات اسپاینال کورد ام ار ای در مانیتورینگ بیماری چیست؟

8)منظور از ام ار ای ری بیس لاین چیست؟

9)منظور از (safety) چیه و قراره چه مواردی را بررسی کنیم

10)در پی ام ال نقش تشخیصی ام ار ای بیش از یافته های سرولوژی است؟

11)Pediatric guideline

12)pregnant guideline

DOI of study:10.1016/S1474-4422(21)00095-8

https://www.sciencedirect.com/science/article/abs/pii/S1474442221000958

Thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 6: journal watch 3

MSCAST — Thu, 11 Nov 2021 16:48:38 +0000

episode 6

talking about two article in JAMA neurology on peri-Vaccination and MS

DOI of first study:10.1001/jamaneurol.2021.3609

https://jamanetwork.com/journals/jamaneurology/fullarticle/2784448

DOI of second study:10.1001/jamaneurol.2021.3599

https://jamanetwork.com/journals/jamaneurology/article-abstract/2784449

thanks' Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode5:MRI in patients with multiple sclerosis...

MSCAST — Mon, 08 Nov 2021 15:59:50 +0000

episode 5

continue talking about global protocol of MRI in MS patients:

1)Central vein sign in new Guideline

2)what is post-contrast T1?

3)spinal cord diagnostic report of MRI

4)در ام ار ای بیس لاین جدا از تشخیص باید جویای چه اطلاعاتی باشیم

5) در گاید لاین جدید برای یکسان شدن تفسیر ها هم صحبت خاصی کرده؟

6)MRI report template

and then talking about Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regression

DOI of first study:10.1016/S1474-4422(21)00095-8

https://www.sciencedirect.com/science/article/abs/pii/S1474442221000958

DOI of second study:jmcp.2021.27.9.1273

https:www.jmcp.org/doi/full/10.18553/jmcp.2021.27.9.1273

thank's Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode 4: journal watch 2

MSCAST — Mon, 25 Oct 2021 16:45:33 +0000

episode 4

talking about Vaccination and MS and then continuing with MS is not associated with an increased risk for severe COVID-19

DOI of first study:10.1136/jnnp-2021-326839

https://jnnp.bmj.com/content/92/10/1033.share

DOI of second study:10.1186/s42466-021-00143-y

https://rdcu.be/cz3Ok

thank's Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode3:MRI in patients with multiple sclerosis...

MSCAST — Wed, 20 Oct 2021 16:30:00 +0000

episode 3

continue talking about global protocol of MRI in MS paitents:

1)توصیه های تشخیصی برای ام اس در استفاده از ام ار ای چیست؟

2)setting of spinal cord

3)optic nerve setting

4)نکات پرکتیکال ام ار ای

and then talking about Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis

DOI of first study:10.1016/S1474-4422(21)00095-8

https://www.sciencedirect.com/science/article/abs/pii/S1474442221000958

DOI of second study:10.1177/1352458511420846

https://journals.sagepub.com/doi/abs/10.1177/1352458511420846

thank's Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode2:journal watch 1

MSCAST — Mon, 18 Oct 2021 17:50:52 +0000

episode 2

talking about concerto and then talking about effects of Tocilizumab Therapy on Circulating B Cells and T Helper Cells in Patients With NMOSD

DOI of first study:10.1177/13524585211032803

https://journals.sagepub.com/doi/abs/10.1177/13524585211032803

DOI of second study:10.3389/fimmu.2021.703931

https://www.frontiersin.org/articles/10.3389/fimmu.2021.703931/full

thank's Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode1:MRI in patients with multiple sclerosis

MSCAST — Thu, 14 Oct 2021 16:02:34 +0000

episode 1

talking about global protocol of MRI in MS paitents:

1)منظور از گلوبال پروتکل در انجام ام ار ای در ام اس چیست؟

2)چه تغییری در پرکتیک نرولوژیست ها ایجاد می کند؟

3)سه گروه تنظیم کننده این پروتکل چه کسانی هستند؟

4)با توجه به نقش ام ار ای در ام اس گلوبال پروتکل چه اهمیتی خواهد داشت؟

and then talking about The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis

DOI of first study:10.1016/S1474-4422(21)00095-8

https://www.sciencedirect.com/science/article/abs/pii/S1474442221000958

DOI of second study:10.1177/13524585211035948

https://journals.sagepub.com/doi/abs/10.1177/13524585211035948

thank's Nano Alvand Co. for sponsorship MScast

https://www.nanoalvand.com/

episode0:intro

MSCAST — Tue, 05 Oct 2021 12:28:22 +0000

ام اس کست چیست؟

چرا ام اس؟

قرار هست اینجا چی بشنویم؟

چه افرادی مخاطب برنامه ی ما هستند؟

با تشکر حامی مالی ام اس کست-شرکت دارویی نانوالوند

www.nanoalvand.com

ما را به همکاران خود معرفی کنید

منتظر ما باشید.